Guardant Health, Inc.
GH
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancā¦ read more
Healthcare
Diagnostics & Research
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$58.88
Price-2.45%
-$1.48
1Y
Price
Market Cap
$7.343b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-52.8%
EBITDA Margin-68.2%
Net Profit Margin-22.1%
Free Cash Flow MarginRevenue
$828.849m
+7.0%
1y CAGR+17.6%
3y CAGR+20.8%
5y CAGREarnings
-$413.818m
+3.9%
1y CAGR-13.2%
3y CAGR-23.9%
5y CAGREPS
-$3.35
+8.4%
1y CAGR-9.0%
3y CAGR-19.3%
5y CAGRBook Value
-$305.475m
$1.332b
Assets$1.637b
Liabilities$1.308b
DebtDebt to Assets
98.2%
-2.8x
Debt to EBITDAFree Cash Flow
-$271.728m
+13.0%
1y CAGR-4.2%
3y CAGR-23.1%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company